Showing results 15 to 34 of 35
< previous
next >
| Issue Date | Title | Author(s) |
| 2023-04 | Galangin as an inflammatory response modulator: An updated overview and therapeutic potential | Thapa, R; Afzal, O; Alfawaz Altamimi, AS; Goyal, A; Almalki, WH; Alzarea, SI; Kazmi, I; Jakhmola, V; Singh, SK; Dua, K; Gilhotra, R; Gupta, G |
| 2023-11-20 | Immunopathology of herpes simplex virus-associated neuroinflammation: Unveiling the mysteries. | Hussain, MS; Gupta, G; Samuel, VP; Almalki, WH; Kazmi, I; Alzarea, SI; Saleem, S; Khan, R; Altwaijry, N; Patel, S; Patel, A; Singh, SK; Dua, K |
| 2023-01 | Janus kinase/signal transducers and activator of transcription (JAK/STAT) and its role in Lung inflammatory disease | Purohit, M; Gupta, G; Afzal, O; Altamimi, ASA; Alzarea, SI; Kazmi, I; Almalki, WH; Gulati, M; Kaur, IP; Singh, SK; Dua, K |
| 2022-12 | Neuropharmacological effect of risperidone: From chemistry to medicine | Bhat, AA; Gupta, G; Afzal, O; Kazmi, I; Al-Abbasi, FA; Alfawaz Altamimi, AS; Almalki, WH; Alzarea, SI; Singh, SK; Dua, K |
| 2023-10-25 | New horizons in lung cancer management through ATR/CHK1 pathway modulation. | Thapa, R; Afzal, O; Bhat, AA; Goyal, A; Alfawaz Altamimi, AS; Almalki, WH; Alzarea, SI; Kazmi, I; Singh, SK; Dua, K; Thangavelu, L; Gupta, G |
| 2022 | PI3K/Akt/mTOR Pathways Inhibitors with Potential Prospects in Non-Small-Cell Lung Cancer. | Alharbi, KS; Shaikh, MAJ; Almalki, WH; Kazmi, I; Al-Abbasi, FA; Alzarea, SI; Imam, SS; Alshehri, S; Ghoneim, MM; Singh, SK; Chellappan, DK; Oliver, BG; Dua, K; Gupta, G |
| 2022-12-13 | Polysaccharide-Based Nanomedicines Targeting Lung Cancer | Bhat, AA; Gupta, G; Alharbi, KS; Afzal, O; Altamimi, ASA; Almalki, WH; Kazmi, I; Al-Abbasi, FA; Alzarea, SI; Chellappan, DK; Singh, SK; MacLoughlin, R; Oliver, BG; Dua, K |
| 2023-08 | Probing the Links: Long Non-Coding RNAs and NF-κB Signalling in Atherosclerosis | Hussain, S; Afzal, O; Gupta, G; Altamimi, ASA; Almalki, WH; Alzarea, SI; Kazmi, I; Kukreti, N; Gupta, S; Sulakhiya, K; Singh, SK; Dua, K |
| - | Quality by Design (QbD) Based Method for Estimation of Xanthohumol in Bulk and Solid Lipid Nanoparticles and Validation | Harish, V; Almalki, WH; Alshehri, A; Alzahrani, A; Gupta, MM; Alzarea, SI; Kazmi, I; Gulati, M; Tewari, D; Gupta, G; Dua, K; Singh, SK |
| 2023 | Recent Developments and Challenges in Molecular-Targeted Therapy of Non-Small-Cell Lung Cancer. | Rohilla, S; Singh, M; Alzarea, SI; Almalki, WH; Al-Abbasi, FA; Kazmi, I; Afzal, O; Altamimi, ASA; Singh, SK; Chellappan, DK; Dua, K; Gupta, G |
| 2022-11-22 | Role of flavonoids in management of various biological targets in Alzheimer's Disease: evidence from preclinical to clinical studies. | Alharbi, KS; Javed Shaikh, MA; Imam, SS; Alshehri, S; Ghoneim, MM; Almalki, WH; Singh, SK; Kumar, D; Kumar, AP; Dua, K; Chellappan, DK; Paudel, KR; Gupta, G |
| - | Role of Medicinal plant‐derived Nutraceuticals as a potential target for the treatment of breast cancer | Alharbi, KS; Almalki, WH; Makeen, HA; Albratty, M; Meraya, AM; Nagraik, R; Sharma, A; Kumar, D; Chellappan, DK; Singh, SK; Dua, K; Gupta, G |
| 2022-06-01 | Sodium alginate based drug delivery in management of breast cancer | Shaikh, MAJ; Alharbi, KS; Almalki, WH; Imam, SS; Albratty, M; Meraya, AM; Alzarea, SI; Kazmi, I; Al-Abbasi, FA; Afzal, O; Altamimi, ASA; Singh, Y; Singh, SK; Dua, K; Gupta, G |
| 2023-03-09 | Sodium alginate-based drug delivery for diabetes management: A review. | Shaikh, MAJ; Gupta, G; Goyal, A; Gupta, MM; Afzal, O; Altamimi, ASA; Alzarea, SI; Almalki, WH; Kazmi, I; Negi, P; Singh, SK; Dua, K |
| 2022-02-25 | Synergism of CD28 Immune Molecule in Late Immunosuppressive Phase of COVID-19: Effectiveness in Vaccinated Individuals. | Alharbi, KS; Singh, Y; Prasad Agrawal, G; Altowayan, WM; Almalki, WH; Sharma, A; Singh, SK; Jha, NK; Chellappan, DK; Dua, K; Gupta, G |
| 2023-05 | The pyroptotic role of Caspase-3/GSDME signalling pathway among various cancer: A Review | Bhat, AA; Thapa, R; Afzal, O; Agrawal, N; Almalki, WH; Kazmi, I; Alzarea, SI; Altamimi, ASA; Prasher, P; Singh, SK; Dua, K; Gupta, G |
| - | The therapeutic role of nutraceuticals targeting the Nrf2/ <scp>HO</scp> ‐1 signaling pathway in liver cancer | Alharbi, KS; Almalki, WH; Albratty, M; Meraya, AM; Najmi, A; Vyas, G; Singh, SK; Dua, K; Gupta, G |
| 2023-08 | Unlocking the potential of mesoporous silica nanoparticles in breast cancer treatment | Thapa, R; Ali, H; Afzal, O; Bhat, AA; Almalki, WH; Alzarea, SI; Kazmi, I; Altamimi, ASA; Jain, N; Pandey, M; Fuloria, NK; Sekar, M; Meenakshi, DU; Jakhmola, V; Singh, SK; Dua, K; Gupta, G |
| 2024-01-03 | UNRAVELING NEAT1'S COMPLEX ROLE IN LUNG CANCER BIOLOGY: A COMPREHENSIVE REVIEW | Hussain, MS; Afzal, O; Gupta, G; Goyal, A; Almalki, WH; Kazmi, I; Alzarea, SI; Altamimi, ASA; Kukreti, N; Chakraborty, A; Singh, SK; Dua, K |
| 2023-08 | Unveiling the connection: long-chain non-coding RNAs and critical signaling pathways in breast cancer | Thapa, R; Afzal, O; Kumar, G; Bhat, AA; Almalki, WH; Alzarea, SI; Kazmi, I; Altamimi, ASA; Subramaniyan, V; Thangavelu, L; Singh, SK; Dua, K |
